Nasdaq · CIK 0001638097
ENTX Entera Bio Ltd.
Insider trading from SEC Form 4. Last filing Jul 18, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Signals
Open-market buys and sells at Entera Bio Ltd., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 21 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2025 | Dana Yaacov-Garbeli Chief Financial Officer | AGrant or award Ordinary Shares, par value NIS 0.0000769 per shareindirect: By A2Z Counseling Ltd. | +26,316 | $0.00 | $0 | 113,047 | Jul 18, 2025 |
| Jul 16, 2025 | Miranda Jayne Toledano Chief Executive Officer | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +136,842 | $0.00 | $0 | 371,715 | Jul 18, 2025 |
| Jul 16, 2025 | Gregory Burshtein Chief of R&D | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +26,316 | $0.00 | $0 | 101,442 | Jul 18, 2025 |
| Jul 16, 2025 | Gregory Burshtein Chief of R&D | AGrant or award Stock Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Jul 18, 2025 |
| Jul 16, 2025 | Dana Yaacov-Garbeli Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +130,000 | $0.00 | $0 | 130,000 | Jul 18, 2025 |
| Jul 16, 2025 | Miranda Jayne Toledano Chief Executive Officer | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +43,860 | $0.00 | $0 | 415,575 | Jul 18, 2025 |
| Jul 16, 2025 | Miranda Jayne Toledano Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Jul 18, 2025 |
| Apr 28, 2025 | Hillel Galitzer Chief Operating Officer | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +26,316 | $0.00 | $0 | 90,573 | Apr 30, 2025 |
| Apr 28, 2025 | Hillel Galitzer Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Apr 30, 2025 |
| Apr 1, 2025 | Gerald M Lieberman director | MOption exercise Ordinary Shares, par value NIS 0.0000769 per share | +23,952 | $1.00 | $24k | 300,160 | Apr 3, 2025 |
| Apr 1, 2025 | Gerald M Lieberman director | MOption exercise Warrant (right to buy)derivative | -23,952 | $0.00 | $0 | 28,509 | Apr 3, 2025 |
| Jan 15, 2025 | Sean Ellis director | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +7,100 | $0.00 | $0 | 134,727 | Jan 17, 2025 |
| Jan 15, 2025 | Gerald M Lieberman director | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +10,717 | $0.00 | $0 | 276,208 | Jan 17, 2025 |
| Jan 15, 2025 | Yonatan Malca director | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +8,216 | $0.00 | $0 | 47,259 | Jan 17, 2025 |
| Jan 15, 2025 | Gerald M Ostrov director | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +8,038 | $0.00 | $0 | 46,936 | Jan 17, 2025 |
| Jan 15, 2025 | Haya Taitel director | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +6,922 | $0.00 | $0 | 64,650 | Jan 17, 2025 |
| Jan 15, 2025 | Sean Ellis director | AGrant or award Stock Option (right to buy)derivative | +28,509 | $0.00 | $0 | 28,509 | Jan 17, 2025 |
| Jan 15, 2025 | Yonatan Malca director | AGrant or award Stock Option (right to buy)derivative | +28,509 | $0.00 | $0 | 28,509 | Jan 17, 2025 |
| Jan 15, 2025 | Gerald M Ostrov director | AGrant or award Stock Option (right to buy)derivative | +28,509 | $0.00 | $0 | 28,509 | Jan 17, 2025 |
| Jan 15, 2025 | Haya Taitel director | AGrant or award Stock Option (right to buy)derivative | +28,509 | $0.00 | $0 | 28,509 | Jan 17, 2025 |
| Jan 15, 2025 | Gerald M Lieberman director | AGrant or award Stock Option (right to buy)derivative | +28,509 | $0.00 | $0 | 28,509 | Jan 17, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Gregory BurshteinChief of R&D
- Sean Ellisdirector
- Hillel GalitzerChief Operating Officer
- Gerald M Liebermandirector
- Yonatan Malcadirector
- Gerald M Ostrovdirector
- Haya Taiteldirector
- Miranda Jayne ToledanoChief Executive Officer
- Dana Yaacov-GarbeliChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.